Company news
ADMA Biologics Inc news in 2026
ADMA Biologics Inc's news releases, calls and decks from 2026, newest first.
ADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update
November 4, 2026
ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026
October 28, 2026
ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process
October 15, 2026
ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 5, 2026
ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026
July 29, 2026
ADMA BIOLOGICS, INC. Scott+Scott Attorneys at Law LLP Investigates ADMA Biologics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ADMA
June 29, 2026
ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update
May 6, 2026
ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older
May 4, 2026
ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026
April 29, 2026
ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research
March 26, 2026
ADMA Biologics Addresses Misleading Short-Seller Report
March 24, 2026
ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative
March 1, 2026
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 25, 2026
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
February 17, 2026
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update
January 11, 2026
ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026
January 4, 2026
Calls in 2026
Decks in 2026
- Investor Presentation (August 2026)
Investor deck · 22 slides · August 2026
- Investor Presentation (January 2026)
Investor deck · 22 slides · Jan 12, 2026